1-3 of 3
Theresa Amoloja
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Use of Tafasitamab (tafa) for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Among Racial and Ethnic Minorities in the United States

Narendranath Epperla, Loretta J. Nastoupil, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Kimberly Saverno
Journal: Blood
Blood (2023) 142 (Supplement 1): 2415.
https://doi.org/10.1182/blood-2023-173456
Published: 2023
Journal Articles

Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting

Kimberly Saverno, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Narendranath Epperla, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 265.
https://doi.org/10.1182/blood-2023-173143
Published: 2023
Journal Articles

Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World

Anthea Peters, Grzegorz S. Nowakowski, Rosy Dabas, Theresa Amoloja, Zhenyi Xue, Caroline Koch, Eva E. Waltl, Isabelle Fleury
Journal: Blood
Blood (2022) 140 (Supplement 1): 3811–3813.
https://doi.org/10.1182/blood-2022-158550
Published: 2022